D
Deleted member 2130
Elite level shower taker
- Joined
- Jun 22, 2019
- Posts
- 3,015
- Reputation
- 4,596
Japanese pharma company Mitsubishi Tanabe Pharma have been developing an MC1R agonist drug called Dersimelagon (MT-7117). It activates MC1R which as a result stimulates the production of Eumelanin (Brown Pigment). MT-7117 is a new non-peptide with a half-life of 96 hours that has a high affinity for primary MC1R with almost full safety approval.
Good news that is already in the process of finishing Phase 3 trials: https://clinicaltrials.gov/ct2/show/NCT05005975
The best part is it can cause tanning without sunlight exposure according to the monkey trials. Which means you can get a tan even if you use tretinoin and can't stay under the sun.
Good news that is already in the process of finishing Phase 3 trials: https://clinicaltrials.gov/ct2/show/NCT05005975
The best part is it can cause tanning without sunlight exposure according to the monkey trials. Which means you can get a tan even if you use tretinoin and can't stay under the sun.
